Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 89
Number of items: 89
  • Open Access
    van den Dijssel, J., van Ham, S. M., ten Brinke, A., & T2B! immunity against SARS-CoV-2 study group (2024). mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses. Journal of autoimmunity, 144, Article 103175. https://doi.org/10.1016/j.jaut.2024.103175
  • Open Access
    Verkerk, T. (2024). Exploring the interplay between immune cells and tumors: Insights into antigen presentation and tumor immune evasion. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Kuijper, L. H., Kreher, C., Elias, G., Claireaux, M., Kerster, G., Bos, A. V., Duurland, M. C., Konijn, V. A. L., Paul, A. G. A., de Jong, N., de Jongh, R., Steenhuis, M., Garcia-Vallejo, J. J., van Gils, M. J., Kuijpers, T. W., Eftimov, F., Rispens, T., van der Schoot, C. E., van Ham, S. M., & ten Brinke, A. (2024). Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection. Frontiers in Immunology, 15, Article 1505719. https://doi.org/10.3389/fimmu.2024.1505719
  • Open Access
    Oskam, S. M. (2024). Immunoglobulin M: Structure, function and specificity in health and autoimmunity. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Lighaam, L. C. (2024). The features and dynamics of IgG4 B cell responses: Insights in B cell-mediated immune tolerance. [Thesis, fully internal, Universiteit van Amsterdam].
  • van Dam, K. P. J., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Busch, M. H., Verstegen, N. J. M., van Ham, S. M., Tas, S. W., & T2B! immunity against SARS-CoV-2 study group (2023). Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations. Journal of autoimmunity, 135, Article 102984. https://doi.org/10.1016/j.jaut.2022.102984
  • Koers, J., Sciarrillo, R., Derksen, N. I. L., Vletter, E. M., Fillié-Grijpma, Y. E., Raveling-Eelsing, E., Graça, N. A. G., Leijser, T., Pas, H. H., van Nijen-Vos, L. L., Braham, M. V. J., Buisman, A.-M., de Jong, J., Schriek, A. I., Tio-Gillen, A. P., Teng, Y. K. O., Steenhuis, M., Swaneveld, F. H., de Taeye, S. W., ... T2B Consortium (2023). Differences in IgG autoantibody Fab glycosylation across autoimmune diseases. Journal of Allergy and Clinical Immunology, 151(6), 1646-1654. https://doi.org/10.1016/j.jaci.2022.10.035
  • Open Access
    van Kempen, Z. L. E., Hogenboom, L., Toorop, A. A., Steenhuis, M., Stalman, E. W., Kummer, L. Y. L., van Dam, K. P. J., Bloem, K., ten Brinke, A., van Ham, S. M., Kuijpers, T. W., Wolbink, G. J., Loeff, F. C., Wieske, L., Eftimov, F., Rispens, T., Strijbis, E. M. M., Killestein, J., & T2B! immunity against SARS-CoV-2 study group (2023). Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis. Annals of Neurology, 93(1), 103-108. https://doi.org/10.1002/ana.26534
  • Open Access
    van Dam, K. P. J., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Busch, M. H., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2023). Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity. BMC Infectious Diseases, 23, Article 332. https://doi.org/10.1186/s12879-023-08298-6
  • Open Access
    Verstegen, N. J. M., Pollastro, S., Unger, P.-PA., Marsman, C., Elias, G., Jorritsma, T., Streutker, M., Bassler, K., Haendler, K., Rispens, T., Schultze, J. L., ten Brinke, A., Beyer, M., & van Ham, S. M. (2023). Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates. eLife, 12, Article e83578. https://doi.org/10.7554/elife.83578
Page 3 of 9